Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle Invasive Bladder Cancer (NMIBC)”

212 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 212 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Not applicableNot Yet RecruitingNCT07781956
What this trial is testing

Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Nanjing First Hospital, Nanjing Medical University 40
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableUnknownNCT04839029
What this trial is testing

Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT

Who this might be right for
Bladder CancerBladder Neoplasm
Benha University 200
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Not applicableUnknownNCT02895620
What this trial is testing

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC

Who this might be right for
Non Muscle Invasive Bladder CancerTreatment by BCG
Institut Claudius Regaud 24
Testing effectiveness (Phase 2)Looking for participantsNCT07307456
What this trial is testing

Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Who this might be right for
Bladder Cancer
Changhai Hospital 31
Large-scale testing (Phase 3)Looking for participantsNCT06929286
What this trial is testing

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center 125
Early research (Phase 1)Active Not RecruitingNCT05483868
What this trial is testing

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more
Aura Biosciences 55
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Testing effectiveness (Phase 2)Looking for participantsNCT05951179
What this trial is testing

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 131
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Early research (Phase 1)Looking for participantsNCT06351904
What this trial is testing

RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 72
Not applicableActive Not RecruitingNCT07511517
What this trial is testing

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell, Bladder
Oslo University Hospital 500
Not applicableLooking for participantsNCT07225127
What this trial is testing

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Who this might be right for
Bladder CancerRecurrent Bladder CancerNon-muscle Invasive Bladder Cancer (NMIBC)
University of Washington 408
Not applicableStudy completedNCT03091764
What this trial is testing

Evaluation of a Patient-Reported Symptom Index for NMIBC

Who this might be right for
Superficial Bladder Cancer
University of Sydney 498
Large-scale testing (Phase 3)Active Not RecruitingNCT05714202
What this trial is testing

TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

Who this might be right for
Bladder Cancer
Janssen Research & Development, LLC 1,135
Next Page